PlainRecalls
FDA Drug Moderate Class II Terminated

Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reported: April 12, 2023 Initiated: March 20, 2023 #D-0491-2023

Product Description

Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reason for Recall

cGMP Deviations

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
a) 3,497 bottles, b) 729 bottles
Distribution
RemedyRepack distributed product to consignees nationwide within the United States
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.. Recalled by RemedyRepack Inc.. Units affected: a) 3,497 bottles, b) 729 bottles.
Why was this product recalled?
cGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 12, 2023. Severity: Moderate. Recall number: D-0491-2023.